CSGP vs IRD · P/E 484, rev $2.74B vs rev $11.0M
CoStar Group Inc (CSGP) versus Opus Genetics, Inc. (IRD) — a side-by-side from cached financials, not a winner call.
CoStar Group Inc (CSGP) is a real estate services company listed on US.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Latest reported CSGP revenue for 2024-12-31 was $2.74B. Net income was $138.7M. Revenue was up 11.5% from 2023-12-31 to 2024-12-31. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
CSGP currently screens at market cap $13.84B and trailing P/E 484.1. IRD currently screens at market cap $35.7M.
Not investment advice. Open the CSGP and IRD stock pages for the full models.
Not investment advice.